Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 768,929 |
|
|||||
| News | - | ||||||
| Day High | 1.28 | Low High |
|||||
| Day Low | 1.21 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Veru Inc | VERU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.035 | 2.89% | 1.245 | 13:34:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.24 | 1.21 | 1.28 | 1.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,869 | 768,929 | $ 1.25 | $ 960,225 | - | 0.36 - 1.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:36:22 | 10 | $ 1.2495 | USD |
Veru Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 180.05M | 146.38M | - | 16.3M | -93.09M | -0.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Veru News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.39 | 1.55 | 1.21 | 1.28 | 2,041,255 | -0.145 | -10.43% |
| 1 Month | 0.7168 | 1.92 | 0.67 | 1.37 | 3,989,601 | 0.5282 | 73.69% |
| 3 Months | 0.5148 | 1.92 | 0.3612 | 0.9749988 | 2,501,858 | 0.7302 | 141.84% |
| 6 Months | 0.86 | 1.92 | 0.36 | 0.8569627 | 1,946,308 | 0.385 | 44.77% |
| 1 Year | 1.29 | 1.92 | 0.36 | 0.9491388 | 1,589,355 | -0.045 | -3.49% |
| 3 Years | 9.05 | 24.55 | 0.36 | 10.40 | 4,390,972 | -7.81 | -86.24% |
| 5 Years | 1.36 | 24.56 | 0.36 | 10.23 | 3,242,275 | -0.115 | -8.46% |
Veru Description
| Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |
